SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-08-001658
Filing Date
2008-03-10
Accepted
2008-03-07 18:53:58
Documents
12
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 ALNYLAM PHARMACEUTICALS, INC. b68134ape10vk.htm 10-K 1304494
2 EX-10.3 2004 STOCK INCENTIVE PLAN, AS AMENDED b68134apexv10w3.htm EX-10.3 43235
3 EX-10.8 2004 EMPLOYEE STOCK PURCHASE PLAN, AS AMENDED b68134apexv10w8.htm EX-10.8 27981
4 EX-21.1 SUBSIDIARIES OF THE REGISTRANT b68134apexv21w1.htm EX-21.1 1959
5 EX-23.1 CONSENT OF PRICEWATERHOUSECOOPERS LLP b68134apexv23w1.htm EX-23.1 1312
6 EX-31.1 SECTION 302 CERTIFICATION OF CEO b68134apexv31w1.htm EX-31.1 8363
7 EX-31.2 SECTION 302 CERTIFICATION OF CFO b68134apexv31w2.htm EX-31.2 8625
8 EX-32.1 SECTION 906 CERTIFICATION OF CEO b68134apexv32w1.htm EX-32.1 3367
9 EX-32.2 SECTION 906 CERTIFICATION OF CFO b68134apexv32w2.htm EX-32.2 3421
10 GRAPHIC b68134apb6813401.gif GRAPHIC 10190
11 GRAPHIC b68134apb6813402.gif GRAPHIC 17527
12 GRAPHIC b68134apb6813403.gif GRAPHIC 8635
  Complete submission text file 0000950135-08-001658.txt   1454775
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50743 | Film No.: 08675551
SIC: 2834 Pharmaceutical Preparations